TH
THISX
ETF
THISX
·
UNKNOWN
·
131 holdings
About THISX
No description available for this ETF.
Fund Details
- Expense Ratio
- —
- Inception Date
- —
- Prev. Close
- 79,14 €
- Exchange
- UNKNOWN
- Currency
- USD
- Holdings As Of
- Apr 10, 2026
- Tracked Holdings
- 65.6%
- HHI Score
- 336,70
- Top Sector
- Healthcare (79.563616%)
Moderate (20,9%)
↗ Recovering
Positive 1W (+1.88%) after negative 1M (-0.23%) — trend may be reversing
47,76%
Moderately Concentrated
Diversified
Concentrated
The top 10 holdings represent 47,76% of the fund. A moderate concentration level — the fund balances top holdings with broader diversification.
Weighted by position size
Weighted avg. of top holdings
▼ -0,28%
ISRG
Intuitive Surgical Inc
UNH
UnitedHealth Group Inc
VRTX
Vertex Pharmaceuticals Inc
BSX
Boston Scientific Corp
TMO
Thermo Fisher Scientific Inc
ALNY
Alnylam Pharmaceuticals Inc
All Holdings (131)
Top 10: 47,76% of fund
| # |
Ticker |
Name |
Weight |
Shares |
Market Value |
| 1 |
LLY
|
Eli Lilly & Co |
11,93% |
1,73 M |
1,35 B |
| 2 |
ISRG
|
Intuitive Surgical Inc |
5,81% |
1,21 M |
657,08 M |
| 3 |
UNH
|
UnitedHealth Group Inc |
5,08% |
1,84 M |
574,68 M |
| 4 |
SYK
|
Stryker Corp |
4,98% |
1,42 M |
563,40 M |
| 5 |
VRTX
|
Vertex Pharmaceuticals Inc |
3,84% |
973 911 |
433,59 M |
| 6 |
BSX
|
Boston Scientific Corp |
3,69% |
3,88 M |
416,71 M |
| 7 |
ARGX
|
Argenx SE |
3,33% |
683 183 |
376,58 M |
| 8 |
DHR
|
Danaher Corp |
3,10% |
1,77 M |
350,11 M |
| 9 |
TMO
|
Thermo Fisher Scientific Inc |
3,07% |
854 687 |
346,54 M |
| 10 |
ALNY
|
Alnylam Pharmaceuticals Inc |
2,93% |
1,02 M |
331,16 M |
| 11 |
GILD
|
Gilead Sciences Inc |
2,41% |
2,45 M |
272,18 M |
| 12 |
INSM
|
Insmed Inc |
2,15% |
2,41 M |
242,60 M |
| 13 |
CI
|
Cigna Group/The |
2,11% |
720 172 |
238,07 M |
| 14 |
ELV
|
Elevance Health Inc |
1,93% |
561 120 |
218,25 M |
| 15 |
ABBV
|
AbbVie Inc |
1,75% |
1,07 M |
198,25 M |
| 16 |
PEN
|
Penumbra Inc |
1,45% |
639 140 |
164,02 M |
| 17 |
BeOne Medicines Ltd
|
BeOne Medicines Ltd |
1,41% |
8,21 M |
159,81 M |
| 18 |
AstraZeneca PLC
|
AstraZeneca PLC |
1,19% |
1,93 M |
134,56 M |
| 19 |
Verona Pharma PLC
|
Verona Pharma PLC |
1,14% |
1,36 M |
128,35 M |
| 20 |
Chugai Pharmaceutica
|
Chugai Pharmaceutical Co Ltd |
1,07% |
2,32 M |
121,39 M |
| 21 |
ASND
|
Ascendis Pharma A/S |
1,06% |
693 353 |
119,67 M |
| 22 |
REGN
|
Regeneron Pharmaceuticals Inc |
1,05% |
226 254 |
118,78 M |
| 23 |
THC
|
Tenet Healthcare Corp |
0,95% |
610 511 |
107,45 M |
| 24 |
NTRA
|
Natera Inc |
0,86% |
573 317 |
96,86 M |
| 25 |
Cencora Inc
|
Cencora Inc |
0,78% |
292 915 |
87,83 M |
| 26 |
HCA
|
HCA Healthcare Inc |
0,76% |
224 900 |
86,16 M |
| 27 |
NBIX
|
Neurocrine Biosciences Inc |
0,69% |
621 659 |
78,14 M |
| 28 |
DGX
|
Quest Diagnostics Inc |
0,65% |
406 310 |
72,99 M |
| 29 |
MOH
|
Molina Healthcare Inc |
0,65% |
244 877 |
72,95 M |
| 30 |
SRRK
|
Scholar Rock Holding Corp |
0,62% |
1,97 M |
69,63 M |
| 31 |
CVS
|
CVS Health Corp |
0,60% |
989 715 |
68,27 M |
| 32 |
Avidity Biosciences
|
Avidity Biosciences Inc |
0,58% |
2,30 M |
65,26 M |
| 33 |
SNY
|
Sanofi SA |
0,55% |
1,30 M |
62,63 M |
| 34 |
Blueprint Medicines
|
Blueprint Medicines Corp |
0,53% |
468 745 |
60,08 M |
| 35 |
KYMR
|
Kymera Therapeutics Inc |
0,53% |
1,37 M |
59,61 M |
| 36 |
Akero Therapeutics I
|
Akero Therapeutics Inc |
0,53% |
1,11 M |
59,48 M |
| 37 |
N/A
|
N/A |
0,52% |
21,07 M |
58,74 M |
| 38 |
SMMT
|
Summit Therapeutics Inc |
0,52% |
2,75 M |
58,46 M |
| 39 |
Sonova Holding AG
|
Sonova Holding AG |
0,48% |
182 689 |
54,48 M |
| 40 |
EXAS
|
Exact Sciences Corp |
0,48% |
1,02 M |
54,14 M |
| 41 |
CAH
|
Cardinal Health Inc |
0,47% |
316 322 |
53,14 M |
| 42 |
MLTX
|
MoonLake Immunotherapeutics |
0,46% |
1,10 M |
51,76 M |
| 43 |
Caris Life Sciences
|
Caris Life Sciences Inc |
0,45% |
1,92 M |
51,22 M |
| 44 |
RVMD
|
Revolution Medicines Inc |
0,45% |
1,38 M |
50,61 M |
| 45 |
Soleno Therapeutics
|
Soleno Therapeutics Inc |
0,43% |
586 455 |
49,13 M |
| 46 |
PCVX
|
Vaxcyte Inc |
0,43% |
1,51 M |
49,04 M |
| 47 |
RGEN
|
Repligen Corp |
0,41% |
370 690 |
46,11 M |
| 48 |
BTSG
|
BrightSpring Health Services Inc |
0,39% |
1,86 M |
43,86 M |
| 49 |
VEEV
|
Veeva Systems Inc |
0,38% |
149 336 |
43,01 M |
| 50 |
CNTA
|
Centessa Pharmaceuticals PLC |
0,37% |
3,21 M |
42,15 M |
| 51 |
IDXX
|
IDEXX Laboratories Inc |
0,37% |
77 131 |
41,37 M |
| 52 |
MDGL
|
Madrigal Pharmaceuticals Inc |
0,36% |
135 801 |
41,10 M |
| 53 |
PRCT
|
PROCEPT BioRobotics Corp |
0,36% |
699 487 |
40,29 M |
| 54 |
RVTY
|
Revvity Inc |
0,34% |
401 827 |
38,86 M |
| 55 |
PTGX
|
Protagonist Therapeutics Inc |
0,34% |
685 458 |
37,89 M |
| 56 |
Alkermes PLC
|
Alkermes PLC |
0,32% |
1,25 M |
35,87 M |
| 57 |
DNLI
|
Denali Therapeutics Inc |
0,31% |
2,50 M |
35,00 M |
| 58 |
AGIO
|
Agios Pharmaceuticals Inc |
0,29% |
990 652 |
32,95 M |
| 59 |
CGON
|
CG oncology Inc |
0,28% |
1,20 M |
31,19 M |
| 60 |
CRNX
|
Crinetics Pharmaceuticals Inc |
0,27% |
1,05 M |
30,29 M |
| 61 |
DXCM
|
Dexcom Inc |
0,25% |
322 061 |
28,11 M |
| 62 |
VERA
|
Vera Therapeutics Inc |
0,24% |
1,17 M |
27,56 M |
| 63 |
ACLX
|
Arcellx Inc |
0,24% |
411 543 |
27,10 M |
| 64 |
RARE
|
Ultragenyx Pharmaceutical Inc |
0,23% |
703 570 |
25,58 M |
| 65 |
IMCR
|
Immunocore Holdings PLC |
0,21% |
773 698 |
24,28 M |
| 66 |
Biohaven Ltd
|
Biohaven Ltd |
0,21% |
1,71 M |
24,12 M |
| 67 |
Apogee Therapeutics
|
Apogee Therapeutics Inc |
0,21% |
552 027 |
23,97 M |
| 68 |
Merus NV
|
Merus NV |
0,21% |
444 988 |
23,41 M |
| 69 |
EHC
|
Encompass Health Corp |
0,20% |
187 885 |
23,04 M |
| 70 |
LEGN
|
Legend Biotech Corp |
0,19% |
601 652 |
21,35 M |
| 71 |
RYTM
|
Rhythm Pharmaceuticals Inc |
0,18% |
324 259 |
20,49 M |
| 72 |
IMNM
|
Immunome Inc |
0,18% |
2,19 M |
20,34 M |
| 73 |
IONS
|
Ionis Pharmaceuticals Inc |
0,18% |
512 286 |
20,24 M |
| 74 |
UTHR
|
United Therapeutics Corp |
0,16% |
61 706 |
17,73 M |
| 75 |
REPL
|
Replimune Group Inc |
0,16% |
1,89 M |
17,60 M |
| 76 |
AMGN
|
Amgen Inc |
0,15% |
62 105 |
17,34 M |
| 77 |
Disc Medicine Inc
|
Disc Medicine Inc |
0,14% |
309 390 |
16,39 M |
| 78 |
KRYS
|
Krystal Biotech Inc |
0,14% |
118 808 |
16,33 M |
| 79 |
Praxis Precision Med
|
Praxis Precision Medicines Inc |
0,14% |
374 760 |
15,76 M |
| 80 |
BEAM
|
Beam Therapeutics Inc |
0,14% |
912 997 |
15,53 M |
| 81 |
CLDX
|
Celldex Therapeutics Inc |
0,14% |
750 770 |
15,28 M |
| 82 |
RAPP
|
Rapport Therapeutics Inc |
0,12% |
1,18 M |
13,38 M |
| 83 |
Tenax Therapeutics I
|
Tenax Therapeutics Inc |
0,11% |
3,20 M |
12,40 M |
| 84 |
CYTK
|
Cytokinetics Inc |
0,10% |
337 628 |
11,16 M |
| 85 |
MCK
|
McKesson Corp |
0,10% |
14 842 |
10,88 M |
| 86 |
TARS
|
Tarsus Pharmaceuticals Inc |
0,09% |
263 625 |
10,68 M |
| 87 |
Pharvaris NV
|
Pharvaris NV |
0,09% |
600 613 |
10,57 M |
| 88 |
ORIC
|
ORIC Pharmaceuticals Inc |
0,09% |
1,03 M |
10,44 M |
| 89 |
SYRE
|
Spyre Therapeutics Inc |
0,09% |
690 693 |
10,34 M |
| 90 |
LNTH
|
Lantheus Holdings Inc |
0,09% |
122 002 |
9,99 M |
| 91 |
ICON PLC
|
ICON PLC |
0,08% |
65 434 |
9,52 M |
| 92 |
Helix Acquisition Co
|
Helix Acquisition Corp II |
0,08% |
878 945 |
9,36 M |
| 93 |
JANX
|
Janux Therapeutics Inc |
0,08% |
372 178 |
8,60 M |
| 94 |
OSCR
|
Oscar Health Inc |
0,07% |
383 141 |
8,21 M |
| 95 |
CAI
|
Caris Life Sciences Inc |
0,07% |
285 603 |
7,63 M |
| 96 |
Bicycle Therapeutics
|
Bicycle Therapeutics PLC |
0,07% |
1,09 M |
7,61 M |
| 97 |
WaVe Life Sciences L
|
WaVe Life Sciences Ltd |
0,06% |
1,07 M |
6,98 M |
| 98 |
Crescent Biopharma I
|
Crescent Biopharma Inc |
0,05% |
360 441 |
5,53 M |
| 99 |
Alector Inc
|
Alector Inc |
0,05% |
3,79 M |
5,31 M |
| 100 |
GPCR
|
Structure Therapeutics Inc |
0,05% |
251 171 |
5,21 M |
| 101 |
SANA
|
Sana Biotechnology Inc |
0,04% |
1,74 M |
4,76 M |
| 102 |
XNCR
|
Xencor Inc |
0,04% |
560 805 |
4,41 M |
| 103 |
GLUE
|
Monte Rosa Therapeutics Inc |
0,04% |
947 439 |
4,27 M |
| 104 |
ZLAB
|
Zai Lab Ltd |
0,04% |
122 117 |
4,27 M |
| 105 |
Kyverna Therapeutics
|
Kyverna Therapeutics Inc |
0,04% |
1,38 M |
4,24 M |
| 106 |
Verily Life Sciences
|
Verily Life Sciences LLC |
0,03% |
113 564 |
3,75 M |
| 107 |
Sensorion SA
|
Sensorion SA |
0,03% |
10,03 M |
3,69 M |
| 108 |
IDYA
|
Ideaya Biosciences Inc |
0,03% |
171 812 |
3,61 M |
| 109 |
Exact Sciences Corp
|
Exact Sciences Corp |
0,03% |
5,59 M |
3,47 M |
| 110 |
ALLO
|
Allogene Therapeutics Inc |
0,03% |
2,75 M |
3,11 M |
| 111 |
Cabaletta Bio Inc
|
Cabaletta Bio Inc |
0,03% |
1,94 M |
2,96 M |
| 112 |
ORKA
|
Oruka Therapeutics Inc |
0,03% |
257 030 |
2,88 M |
| 113 |
PAX Labs Inc
|
PAX Labs Inc |
0,02% |
8,40 M |
2,60 M |
| 114 |
Aura Biosciences Inc
|
Aura Biosciences Inc |
0,02% |
327 622 |
2,05 M |
| 115 |
RLAY
|
Relay Therapeutics Inc |
0,02% |
569 278 |
1,97 M |
| 116 |
Lyell Immunopharma I
|
Lyell Immunopharma Inc |
0,02% |
214 565 |
1,90 M |
| 117 |
Cargo Therapeutics I
|
Cargo Therapeutics Inc |
0,02% |
426 331 |
1,76 M |
| 118 |
Rocket Pharmaceutica
|
Rocket Pharmaceuticals Inc |
0,01% |
688 253 |
1,69 M |
| 119 |
TRDA
|
Entrada Therapeutics Inc |
0,01% |
219 570 |
1,48 M |
| 120 |
IOVA
|
Iovance Biotherapeutics Inc |
0,01% |
737 385 |
1,27 M |
| 121 |
Voyager Therapeutics
|
Voyager Therapeutics Inc |
0,01% |
350 448 |
1,09 M |
| 122 |
ARVN
|
Arvinas Inc |
0,01% |
135 859 |
999 922,24 |
| 123 |
Orchestra BioMed Hol
|
Orchestra BioMed Holdings Inc |
0,01% |
290 668 |
778 990,24 |
| 124 |
ANNX
|
Annexon Inc |
0,01% |
258 836 |
621 206,4 |
| 125 |
Prelude Therapeutics
|
Prelude Therapeutics Inc |
0,00% |
661 222 |
535 193,09 |
| 126 |
Generation Bio Co
|
Generation Bio Co |
0,00% |
1,43 M |
457 279,18 |
| 127 |
Ginkgo Bioworks Hold
|
Ginkgo Bioworks Holdings Inc |
0,00% |
28 555 |
321 243,75 |
| 128 |
Revolution Medicines
|
Revolution Medicines Inc |
0,00% |
198 505 |
53 596,35 |
| 129 |
GeneDx Holdings Corp
|
GeneDx Holdings Corp |
0,00% |
206 747 |
13 645,3 |
| 130 |
SomaLogic Inc
|
SomaLogic Inc |
0,00% |
90 179 |
1 037,06 |
| 131 |
Gyroscope Therapeuti
|
Gyroscope Therapeutics Ltd |
0,00% |
13,26 M |
0,0 |
Showing top 10 of 131 holdings
·
Listed: 91,23%
·
8,77% in other positions
{"event":"ticker_viewed","properties":{"ticker":"THISX","listing_kind":"etf","pathname":"/etfs/thisx","exchange":"UNKNOWN"}}